IC

Initiative Capital

Europe, Alsace, France, Sausheim

Description

Initiative Capital is a Sausheim-based venture capital firm that supports entrepreneurs who are unable to find financing from banks.

Investor Profile

Initiative Capital has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (25%)
  • Series Unknown (25%)
  • Series B (25%)
  • Series A (25%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical Device
  • Education
  • Internet
  • Sports
  • Video
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Initiative Capital frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1
Sectoral Asset Management
North America, Quebec, Canada, Montréal
Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 2
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 1
NGN Capital
North America, New York, United States, New York
Co-Investments: 1
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 1
Nomura International
Europe, England, United Kingdom, London
Co-Investments: 1
AA
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 1

What are some of recent deals done by Initiative Capital?

Endosense

Geneva, Geneve, Switzerland

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CNov 27, 2012
Amount Raised: $40,300,000
Xigen

Epalinges, Vaud, Switzerland

Xigen, a biopharmaceutical company, develops therapeutics to inhibit intracellular protein interactions.

BiopharmaBiotechnologyTherapeutics
Series ASep 6, 2005
Amount Raised: $21,000,000
Addex Therapeutics

Plan-les-ouates, Geneve, Switzerland

Addex Therapeutics is a biopharmaceutical company that discovers and develops allosteric modulators for human health.

BiotechnologyHealth CareMedicalPharmaceutical
Series BMay 17, 2004
Amount Raised: $39,644,926
Dartfish

Fribourg, Fribourg, Switzerland

Dartfish develops online and offline video solutions for coaches, athletes, pros, students, teachers, healthcare, and sports organizations.

EducationHealth CareInternetSportsVideo
Series UnknownJul 12, 2002
Amount Raised: $2,969,888